Chapters

Transcript

Video

What guidance can you give when the F1M CGP profile reveals multiple relevant, actionable mutations? Why select targeted therapies when multiple genomic alterations or rearrangements co-exist?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Samuel Klempner, MD

Samuel Klempner, MD

Director of Precision Medicine
The Angeles Clinic and Research Institute
Cedars-Sinai Medical Center
Los Angeles, CA